Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G

Introduction: Immunotherapy is being used for the past five years either as first line or second line treatment with great results. Chemotherapy and radiotherapy have been also used as combination to immunotherapy to further enhance this type of treatment. Intratumoral treatment has been previously...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Zarogoulidis, Paul, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Zhou, Jun, Wang, Qin, Wang, Xiangqi, Xia, Ying, Ding, Yinfeng, Bai, Chong, Kosmidis, Christoforos, Sapalidis, Konstantinos, Sardeli, Chrysanthi, Tsakiridis, Kosmas, Zaric, Bojan, Kovacevic, Tomi, Stojsic, Vladimir, Sarcev, Tatjana, Bursac, Daliborka, Kukic, Biljana, Baka, Sofia, Athanasiou, Evagelia, Hatzibougias, Dimitrios, Michalopoulou-Manoloutsiou, Electra, Petanidis, Savvas, Drougas, Dimitris, Drevelegas, Konstantinos, Paliouras, Dimitris, Barbetakis, Nikolaos, Vagionas, Anastasios, Freitag, Lutz, Lallas, Aimilios, Boukovinas, Ioannis, Petridis, Dimitris, Ioannidis, Aris, Matthaios, Dimitris, Romanidis, Konstantinos, Karapantzou, Chrisanthi
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2021
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040712/
https://ncbi.nlm.nih.gov/pubmed/33854617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.55322
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料